Isthmus Project's portfolio has expanded once again! AIQ Solutions plans to revolutionize the way oncologists manage the care of patients with metastatic disease with a new product called TRAQinform IQ, currently in use at 12 hospitals including UW Health. Read more about the technology and AIQ's team below. A big thank you to Eric Horler, Robert Jeraj, and Glenn Liu for taking time to contribute to the article! https://lnkd.in/gDKkpMWr
AIQ Solutions
医疗设备制造业
Madison，Wisconsin 1,253 位关注者
Novel software medical device for managing late-stage cancer. Oncology clinical decision support SaaS.
关于我们
AIQ Solutions is a group of passionate entrepreneurs, scientists, and engineers with a vision to improve treatment outcomes for patients with a wide range of complex diseases, all around the world. Leveraging a strong foundation of intellectual property, AIQ is continuously innovating. By combining ingenuity with rigorous clinical validation, AIQ is changing how clinicians manage complex diseases.
- 网站
-
https://www.aiq-solutions.com
AIQ Solutions的外部链接
- 所属行业
- 医疗设备制造业
- 规模
- 11-50 人
- 总部
- Madison，Wisconsin
- 类型
- 私人持股
- 创立
- 2016
- 领域
- Medical software、Clinical decision support、Therapy optimization、Clinical trials、Artificial intelligence、Deep learning、Treatment response和Oncology
地点
-
主要
获取路线
8000 Excelsior Drive
Suite 400
US，Wisconsin，Madison，53717
AIQ Solutions员工
-
Eric Horler
Chief Executive Officer at AIQ Solutions
-
Russell Francis
AIQ Solutions Australia - AI Medical Device Company revolutionising the understanding of treatment response to improve patient outcomes
-
Vijay Parthasarathy, PhD, MBA
Vice President of Product Management | Board Observer | Early-stage venture leader | Long-distance running enthusiast
-
Gregg Fergus
动态
-
Eric Horler, AIQ Solutions CEO, was invited by?AdvaMed?to present our TRAQinform IQ technology at?a reception showcasing AI-enabled medical devices and technologies. The event provided more clarity to lawmakers on how AI imaging technologies are shaping the way medical providers diagnose and treat diseases. AdvaMed advocates for patient access to safe, effective, and innovative technologies that save and improve lives.??The event was honorarily?co-hosted by Senators Martin Heinrich (D-NM) and Mike Rounds (R-SD), both co-chairs of the Senate AI Caucus.?
-
-
Eric Horler, AIQ Solutions CEO, was invited by?AdvaMed?to present our TRAQinform IQ technology at?a reception showcasing AI-enabled medical devices and technologies. The event provided more clarity to lawmakers on how AI imaging technologies are shaping the way medical providers diagnose and treat diseases. AdvaMed advocates for patient access to safe, effective, and innovative technologies that save and improve lives.??The event was honorarily?co-hosted by Senators Martin Heinrich (D-NM) and Mike Rounds (R-SD), both co-chairs of the Senate AI Caucus.?
-
-
Tim Perk, PhD, VP of Research at AIQ, will be presenting a poster at ASCO exploring the the relationship between blood biomarkers (ctDNA) and imaging features that are spatially localizable (TRAQinform IQ technology). The impact of this correlation relative to improved prognostication will be discussed.
-
-
Congratulations Victor!
I am happy to share that we just published an article in the prestigious European Journal of Nuclear Medicine and Medical Imaging (EJNMMI). This work is a part of my Ph.D. investigation at the UW-Madison Department of Medical Physics. It is the first time that comprehensive image information was used to predict the outcome of theranostics in neuroendocrine tumor patients. We showed that increasing image information utilization leads to better outcome prediction! This work is a direct application of the lesion-tracking technology we developed here at UW-Madison in partnership with AIQ Solutions, which has brought it to the marketplace! I am proud to see our technology being used beyond academic walls. If you want to read more about lesion tracking: https://lnkd.in/dWzQjqvN https://lnkd.in/dwhHeQCZ Special thanks to my colleagues who collaborated with this work, Brayden Schott, Alison Deatsch, Ph.D., and to my Ph.D. advisor, Dr. Robert Jeraj. https://lnkd.in/dJ35kt-q
Models using comprehensive, lesion-level, longitudinal [68Ga]Ga-DOTA-TATE PET-derived features lead to superior outcome prediction in neuroendocrine tumor patients treated with [177Lu]Lu-DOTA-TATE - European Journal of Nuclear Medicine and Molecular Imaging
link.springer.com
-
We just published a new research paper in Physics in Medicine and Biology. This methodology was patented by the?Wisconsin Alumni Research Foundation (WARF) and currently contributes to the products offered by AIQ Solutions in the marketplace. I am happy to see our research being translated! Go check it out, if you are into treatment response assessment! https://lnkd.in/dQ4bwRRb
-
-
Every day, innovators across the MATTER community are building new solutions that accelerate innovation, advance care and improve lives. Over the last three months, MATTER startups completed raises, fostered impactful partnerships and much more. There's no shortage of good news to celebrate in the MATTER. Learn more about our collective accomplishments here: https://bit.ly/3wwCljD Acorai, Augment Therapy, Able Innovations, CARI Health, Dina, Enhanced Medical Nutrition, Medipixel, Partum Health, Rhaeos, Xploro?, AIRS Medical, AIQ Solutions, CareAcademy, Densitas Inc., LIVEMED Telehealth?, Neurotrack, Somnea Health, TCARE, Inc., Vivante Health, AI Nexus Healthcare, Blueprint, C the Signs, Clearstep, CareYaya, Dimension Inx, FemGevity, RxE2, Soundwave Hearing, LLC, VUNO Inc.
MATTER startup shoutouts: Winter 2023-24
matter.health